跳至主要内容
临床试验/NCT04251988
NCT04251988进行中(未招募)不适用

The Effectiveness of Virtual Reality (VR) to Reduce Pain and Anxiety During Genitourinary (GU) Scans

Children's Hospital Los Angeles2 个研究点 分布在 1 个国家目标入组 410 人开始时间: 2020年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
410
试验地点
2
主要终点
Change in Pain during VCUG - Pain Visual Analog Scale

研究概览

简要总结

This study aims to test the effectiveness of virtual reality (VR) in reducing pain and anxiety in children undergoing voiding cystourethrograms (VCUG) at Children's Hospital Los Angeles (CHLA). A voiding cystourethrogram is a genitourinary diagnostic scan that provides important urological information, specifically the filling and releasing of the bladder. This information can help diagnose urological issues in children. However, this procedure requires catheterization, which is understood to be a painful and anxiety-provoking procedure. This study will test the effectiveness of VR as a non-pharmaceutical intervention to relieve pain and anxiety in pediatric patients undergoing VCUGs.

详细描述

Background: VCUGs are genitourinary diagnostic scans that provide valuable medical information for pediatric patients with urological issues. However, these scans require catheterization, which can be anxiety-provoking, painful, and in some cases traumatic. Previous studies have assessed the use of pharmacological agents to address pain and anxiety during these procedures, but few studies exist examining non-pharmacological interventions in a methodologically rigorous way. As pharmacological interventions are associated with numerous side effects, and may not be appropriate for all pediatric patients, effective non-pharmacological interventions are needed for patients undergoing VCUGs.

Aims: This study aims to determine the effectiveness of virtual reality (VR) in reducing pain and anxiety among children undergoing VCUGs at CHLA. This study will also assess patient, parent, and provider satisfaction with VR, and ease of completing VCUGs using VR vs. the standard of care.

Study Population: CHLA patients aged 5-21 years receiving VCUGs at CHLA. Methods: A stratified randomization scheme will be used to assign patients aged 5-21 undergoing VCUG scans to receive the standard of care (i.e. caregiver presence in the room and Child Life Specialists in the room if desired), or the standard of care plus VR. Individuals assigned to the VR arm will be fitted with a Samsung head-tracking system, and will play an AppliedVR game prior to and during catheterization. Standardized questionnaires will be administered to patients and caregivers before and after the procedure to measure pain and anxiety. Satisfaction questionnaires will be administered post-procedure.

Significance: VR is a non-invasive intervention that, if effective, could become part of a standard protocol to reduce pain and anxiety among children undergoing VCUGs. As there is a dearth of knowledge regarding non-pharmacologic interventions for children receiving VCUGs, this study will provide a foundation to inform future research on VR use among pediatric urology patients.

See 'References' for Brief Summary References

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
5 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Child is currently taking pain medication or anxiolytic medication, including midazolam
  • Child has a psychiatric disorder (i.e. anxiety, psychotic, thought disorder), organic brain syndrome, intellectual disability, Autism Spectrum Disorder, or other known cognitive/neurological disorder
  • Child has visual, auditory, or tactile deficit that would interfere with the ability to complete the experimental tasks
  • Child has a history of seizure disorder
  • Child is currently sick with flu-like symptoms or experiencing a headache or earache
  • Child has known or suspected motion sickness
  • Child catheterizes regularly or has an insensate urethra
  • Languages other than English and Spanish will be excluded given that the proposed measures have not been standardized for use in other languages.

结局指标

主要结局

Change in Pain during VCUG - Pain Visual Analog Scale

时间窗: Will be administered to participants approximately 20 minutes before the start of the VCUG, and within 15 minutes following the end of the VCUG.

Participant levels of pain will be assessed using the Pain Visual Analog Scale (min. score = 0; max. score = 100. Higher score = higher pain)

次要结局

  • Change in Anxiety during VCUG - Facial Affective Scale(Will be administered to participants approximately 20 minutes before the start of the VCUG, and within 15 minutes following the end of the VCUG.)
  • Baseline Anxiety before VCUG - Anxiety Sensitivity Index(Will be administered to participants approximately 20 minutes before the start of the VCUG.)
  • Change in Pain during VCUG - Colored Analog Scale(Will be administered to participants approximately 20 minutes before the start of the VCUG, and within 15 minutes following the end of the VCUG.)
  • Change in Anxiety during VCUG - Procedural Anxiety Visual Analog Scale(Will be administered to participants approximately 20 minutes before the start of the VCUG, and within 15 minutes following the end of the VCUG.)
  • Change in Pain during VCUG - Faces Pain Scale-Revised(Will be administered to participants approximately 20 minutes before the start of the VCUG, and within 15 minutes following the end of the VCUG.)
  • Satisfaction with VR(Questionnaires will be administered to participants within 15 minutes following the end of the VCUG.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andy Y. Chang

Attending Physician; Vice Chief, Division of Pediatric Urology

Children's Hospital Los Angeles

研究点 (2)

Loading locations...

相似试验